Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Procalcitonin and C-reactive protein levels in infective attacks of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003
Levels of procalcitonin, neopterin, C-reactive protein and pro-atrial natriuretic peptide in patients with community-acquired pneumonia and its kinetic according to the severity and the development of complications Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010
Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004
Is there a relationship between severity of COPD and C-reactive protein (CRP) levels? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012
Association between C-reactive protein levels and outcome in acute lung injury in children Source: Annual Congress 2011 - Issues in paediatric and neonatal intensive care Year: 2011
Can Neutrophil/lymphocyte Ratio, C-reactive protein (CRP) and Procalcitonin predict the hospitalization time in patients with lower tract respiratory infections ? Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
Usefulness of troponin-1, lactate and c-reactive protein as a prognostic markers in critically ill, non cardiac patients Source: Eur Respir J 2005; 26: Suppl. 49, 436s Year: 2005
Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008
Prognosis value of initial C-reactive protein (CRP) assay in patients with community acquired pneumonia Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients Source: Eur Respir J 2006; 27: 902-907 Year: 2006
Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017
C-reactive protein/albumin ratio as a prognostic biomarker in critically ill septic patients: a prospective study Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020
Usefulness of troponin-I, lactate, C-reactive protein as a prognostic markers in critically ill non-cardiac patients Source: Eur Respir J 2006; 28: Suppl. 50, 181s Year: 2006